Paula Kroon

754 total citations
10 papers, 539 citations indexed

About

Paula Kroon is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Paula Kroon has authored 10 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Paula Kroon's work include CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and FOXO transcription factor regulation (2 papers). Paula Kroon is often cited by papers focused on CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and FOXO transcription factor regulation (2 papers). Paula Kroon collaborates with scholars based in Netherlands, Austria and Spain. Paula Kroon's co-authors include Inge Verbrugge, Vincent M. Mann, Matthew Simms, Somsundaram Chettiar, Anne T. Collins, Norman J. Maitland, Greta Rodrigues, Pui‐Kai Li, Paul A. Berry and Deepak Bhasin and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Paula Kroon

9 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paula Kroon Netherlands 6 283 271 135 125 98 10 539
Lotte Hiddingh United States 8 203 0.7× 214 0.8× 139 1.0× 109 0.9× 88 0.9× 9 523
Carlos R. Gil Del Alcazar United States 7 205 0.7× 247 0.9× 73 0.5× 109 0.9× 80 0.8× 9 440
Agnete S. T. Engelsen Norway 13 212 0.7× 252 0.9× 203 1.5× 193 1.5× 83 0.8× 27 600
Donna Guo United States 5 279 1.0× 194 0.7× 175 1.3× 143 1.1× 43 0.4× 5 511
Patrick Grierson United States 14 206 0.7× 271 1.0× 119 0.9× 85 0.7× 44 0.4× 38 514
Daniele Runci Italy 8 335 1.2× 365 1.3× 305 2.3× 218 1.7× 60 0.6× 9 750
Amy Saur Conway United States 6 267 0.9× 252 0.9× 173 1.3× 51 0.4× 116 1.2× 8 584
Emily Pittman United States 9 285 1.0× 205 0.8× 99 0.7× 96 0.8× 126 1.3× 22 508
Xiangdong Zhao China 14 210 0.7× 324 1.2× 120 0.9× 196 1.6× 47 0.5× 24 580
Hecheng Zhu China 14 110 0.4× 295 1.1× 132 1.0× 157 1.3× 96 1.0× 29 530

Countries citing papers authored by Paula Kroon

Since Specialization
Citations

This map shows the geographic impact of Paula Kroon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Kroon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Kroon more than expected).

Fields of papers citing papers by Paula Kroon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Kroon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Kroon. The network helps show where Paula Kroon may publish in the future.

Co-authorship network of co-authors of Paula Kroon

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Kroon. A scholar is included among the top collaborators of Paula Kroon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Kroon. Paula Kroon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ma, Jennifer, Xiangjun Kong, Paula Kroon, et al.. (2024). Non-clinical evaluation of NT-175, an autologous T cell product engineered to express an HLA-A*02:01-restricted TCR targeting TP53 R175H and resistant to TGF-b inhibition.. Journal of Clinical Oncology. 42(16_suppl). 2560–2560.
2.
Ma, Jennifer, Xiangjun Kong, Paula Kroon, et al.. (2024). Non-clinical evaluation of NT-112, an autologous T cell product engineered to express an HLA-C*08:02-restricted TCR targeting KRAS G12D and resistant to TGF-b inhibition.. Journal of Clinical Oncology. 42(16_suppl). e14533–e14533. 2 indexed citations
3.
Kok, Lianne, Paula Kroon, Xiangjun Kong, et al.. (2022). 239 Engineering of potency-enhanced TCR-edited T cells for shared neoantigen-targeted cancer immunotherapy. Regular and Young Investigator Award Abstracts. A253–A253. 1 indexed citations
4.
Marques, Carolina, Thomas Unterkircher, Paula Kroon, et al.. (2021). NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1. eLife. 10. 58 indexed citations
5.
Oldrini, Barbara, Quanhua Mu, Paula Kroon, et al.. (2020). MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas. Nature Communications. 11(1). 3883–3883. 143 indexed citations
6.
Kroon, Paula, Marit M. van Buuren, Ton N. Schumacher, et al.. (2019). Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity. Cancer Immunology Research. 7(4). 670–682. 41 indexed citations
7.
Kroon, Paula, Jules Gadiot, Alessia Gasparini, et al.. (2016). Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma. Cancer Immunology Immunotherapy. 65(6). 753–763. 26 indexed citations
8.
Gadiot, Jules, Ekaterina S. Jordanova, Ruben Lacroix, et al.. (2016). Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma. OncoImmunology. 5(12). e1238557–e1238557. 120 indexed citations
9.
Song, Ji‐Ying, Jules Gadiot, Adriaan D. Bins, et al.. (2016). Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in PtenLoxP/LoxP;BrafCA/+ Mice. International Journal of Molecular Sciences. 17(12). 2149–2149. 3 indexed citations
10.
Kroon, Paula, Paul A. Berry, Michael J. Stower, et al.. (2013). JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells. Cancer Research. 73(16). 5288–5298. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lotte Hiddingh Breakdown of academic impact, for papers by Carlos R. Gil Del Alcazar Breakdown of academic impact, for papers by Agnete S. T. Engelsen Breakdown of academic impact, for papers by Donna Guo Breakdown of academic impact, for papers by Patrick Grierson Breakdown of academic impact, for papers by Daniele Runci Breakdown of academic impact, for papers by Amy Saur Conway Breakdown of academic impact, for papers by Emily Pittman Breakdown of academic impact, for papers by Xiangdong Zhao Breakdown of academic impact, for papers by Hecheng Zhu
Rankless by CCL
2026